
Shortened Drug Regimens for the Treatment of Active Tuberculosis
Author(s) -
Kendra Brett,
Melissa Severn
Publication year - 2021
Publication title -
canadian journal of health technologies
Language(s) - English
Resource type - Journals
ISSN - 2563-6596
DOI - 10.51731/cjht.2021.137
Subject(s) - regimen , medicine , tuberculosis , active tuberculosis , drug , surgery , pharmacology , mycobacterium tuberculosis , pathology
For treating active tuberculosis (TB), some 4-month treatment regimens may be as effective and safe as the standard 6-month treatment regimen. However, there are also 4-month treatment regimens that seem to be less effective than the 6-month treatment regimen for treating active TB. The effectiveness of these shortened treatment regimens depends on the combination of drugs and the dose schedule.
For treating active TB, a 3-month treatment regimen appears to be less effective than the standard 6-month regimen, as it is associated with a higher rate of TB recurring within 2 years after completing treatment.